Targeting Undruggable Targets: Advancing Kidney-Targeted Therapies Through Molecular Engineering to Overcome Tissue Targeting Barriers

• Applying molecular engineering approaches to address “undruggable” targets
• Addressing barriers to renal tissue targeting
• Targeting dysregulated/diseased cells to restore renal function

Speakers:

Thomas Miller

SVP, Head of Research

Walden Biosciences